Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Journal
Age
Showing 1 to 12 of 1646 entries
Sorted by: Best Match Show Resources per page
Cholestipol hydrochloride, a new hypolipidemic drug: a two-year study-summary.

Advances in experimental medicine and biology

Cooper EE, Michel AM.
PMID: 920358
Adv Exp Med Biol. 1977;82:191-4. doi: 10.1007/978-1-4613-4220-5_36.

No abstract available.

Cite
Cooper EE, Michel AM. Cholestipol hydrochloride, a new hypolipidemic drug: a two-year study-summary. Adv Exp Med Biol. 1977;82:191-4doi: 10.1007/978-1-4613-4220-5_36.
Cooper, E. E., & Michel, A. M. (1977). Cholestipol hydrochloride, a new hypolipidemic drug: a two-year study-summary. Advances in experimental medicine and biology, 82191-4. https://doi.org/10.1007/978-1-4613-4220-5_36
Cooper, E E, and Michel, A M. "Cholestipol hydrochloride, a new hypolipidemic drug: a two-year study-summary." Advances in experimental medicine and biology vol. 82 (1977): 191-4. doi: https://doi.org/10.1007/978-1-4613-4220-5_36
Cooper EE, Michel AM. Cholestipol hydrochloride, a new hypolipidemic drug: a two-year study-summary. Adv Exp Med Biol. 1977;82:191-4. doi: 10.1007/978-1-4613-4220-5_36. PMID: 920358.
Copy Download .nbib Format: NLM
Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat.

Gastroenterology

Heuman DM, Mills AS, McCall J, Hylemon PB, Pandak WM, Vlahcevic ZR.
PMID: 1983822
Gastroenterology. 1991 Jan;100(1):203-11. doi: 10.1016/0016-5085(91)90602-h.

The protective effect of ursodeoxycholate conjugates against bile salt hepatotoxicity was studied in chronic bile fistula rats. Taurochenodeoxycholate or taurodeoxycholate, infused intraduodenally at 24 or 16 mumols/100 g rat per hour, respectively, caused cholestasis and severe hepatocellular necrosis within...

Cite
Heuman DM, Mills AS, McCall J, et al. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat. Gastroenterology. 1991;100(1):203-11doi: 10.1016/0016-5085(91)90602-h.
Heuman, D. M., Mills, A. S., McCall, J., Hylemon, P. B., Pandak, W. M., & Vlahcevic, Z. R. (1991). Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat. Gastroenterology, 100(1), 203-11. https://doi.org/10.1016/0016-5085(91)90602-h
Heuman, D M, et al. "Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat." Gastroenterology vol. 100,1 (1991): 203-11. doi: https://doi.org/10.1016/0016-5085(91)90602-h
Heuman DM, Mills AS, McCall J, Hylemon PB, Pandak WM, Vlahcevic ZR. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat. Gastroenterology. 1991 Jan;100(1):203-11. doi: 10.1016/0016-5085(91)90602-h. PMID: 1983822.
Copy Download .nbib Format: NLM
Chronic cholestasis, paucity of bile ducts, red cell aplasia, and the Stevens-Johnson syndrome. An ampicillin-associated case.

Gastroenterology

Cavanzo FJ, Garcia CF, Botero RC.
PMID: 2116345
Gastroenterology. 1990 Sep;99(3):854-6. doi: 10.1016/0016-5085(90)90980-f.

The unique case of severe chronic cholestasis with paucity of bile ducts accompanied by pure red cell aplasia and the Stevens-Johnson syndrome in a 35-year-old woman after ampicillin ingestion is presented. The patient improved gradually and is asymptomatic 4...

Cite
Cavanzo FJ, Garcia CF, Botero RC. Chronic cholestasis, paucity of bile ducts, red cell aplasia, and the Stevens-Johnson syndrome. An ampicillin-associated case. Gastroenterology. 1990;99(3):854-6doi: 10.1016/0016-5085(90)90980-f.
Cavanzo, F. J., Garcia, C. F., & Botero, R. C. (1990). Chronic cholestasis, paucity of bile ducts, red cell aplasia, and the Stevens-Johnson syndrome. An ampicillin-associated case. Gastroenterology, 99(3), 854-6. https://doi.org/10.1016/0016-5085(90)90980-f
Cavanzo, F J, et al. "Chronic cholestasis, paucity of bile ducts, red cell aplasia, and the Stevens-Johnson syndrome. An ampicillin-associated case." Gastroenterology vol. 99,3 (1990): 854-6. doi: https://doi.org/10.1016/0016-5085(90)90980-f
Cavanzo FJ, Garcia CF, Botero RC. Chronic cholestasis, paucity of bile ducts, red cell aplasia, and the Stevens-Johnson syndrome. An ampicillin-associated case. Gastroenterology. 1990 Sep;99(3):854-6. doi: 10.1016/0016-5085(90)90980-f. PMID: 2116345.
Copy Download .nbib Format: NLM
Intrahepatic cholestasis after griseofulvin administration.

Gastroenterology

Chiprut RO, Viteri A, Jamroz C, Dyck WP.
PMID: 131731
Gastroenterology. 1976 Jun;70(6):1141-3.

The occurrence of cholestatic jaundice in a patient receiving griseofulvin is described. The clinical manifestations, laboratory features, and pathological lesion of drug-induced hepatotoxicity are discussed. Complete recovery followed the discontinuation of drug administration. The potential hepatotoxicity of griseofulvin and...

Cite
Chiprut RO, Viteri A, Jamroz C, et al. Intrahepatic cholestasis after griseofulvin administration. Gastroenterology. 1976;70(6):1141-3
Chiprut, R. O., Viteri, A., Jamroz, C., & Dyck, W. P. (1976). Intrahepatic cholestasis after griseofulvin administration. Gastroenterology, 70(6), 1141-3.
Chiprut, R O, et al. "Intrahepatic cholestasis after griseofulvin administration." Gastroenterology vol. 70,6 (1976): 1141-3.
Chiprut RO, Viteri A, Jamroz C, Dyck WP. Intrahepatic cholestasis after griseofulvin administration. Gastroenterology. 1976 Jun;70(6):1141-3. PMID: 131731.
Copy Download .nbib Format: NLM
Cholestatic jaundice associated with flurazepam hydrochloride.

Annals of internal medicine

Fang MH, Ginsberg AL, Dobbins WO.
PMID: 28685
Ann Intern Med. 1978 Sep;89(3):363-4. doi: 10.7326/0003-4819-89-3-363.

No abstract available.

Cite
Fang MH, Ginsberg AL, Dobbins WO. Cholestatic jaundice associated with flurazepam hydrochloride. Ann Intern Med. 1978;89(3):363-4doi: 10.7326/0003-4819-89-3-363.
Fang, M. H., Ginsberg, A. L., & Dobbins, W. O. (1978). Cholestatic jaundice associated with flurazepam hydrochloride. Annals of internal medicine, 89(3), 363-4. https://doi.org/10.7326/0003-4819-89-3-363
Fang, M H, et al. "Cholestatic jaundice associated with flurazepam hydrochloride." Annals of internal medicine vol. 89,3 (1978): 363-4. doi: https://doi.org/10.7326/0003-4819-89-3-363
Fang MH, Ginsberg AL, Dobbins WO. Cholestatic jaundice associated with flurazepam hydrochloride. Ann Intern Med. 1978 Sep;89(3):363-4. doi: 10.7326/0003-4819-89-3-363. PMID: 28685.
Copy Download .nbib Format: NLM
Hepatic complications of androgen therapy.

Gastroenterology

Murray-Lyon IM, Westaby D, Paradinas F.
PMID: 199526
Gastroenterology. 1977 Dec;73(6):1461.

No abstract available.

Cite
Murray-Lyon IM, Westaby D, Paradinas F. Hepatic complications of androgen therapy. Gastroenterology. 1977;73(6):1461
Murray-Lyon, I. M., Westaby, D., & Paradinas, F. (1977). Hepatic complications of androgen therapy. Gastroenterology, 73(6), 1461.
Murray-Lyon, I M, et al. "Hepatic complications of androgen therapy." Gastroenterology vol. 73,6 (1977): 1461.
Murray-Lyon IM, Westaby D, Paradinas F. Hepatic complications of androgen therapy. Gastroenterology. 1977 Dec;73(6):1461. PMID: 199526.
Copy Download .nbib Format: NLM
Hepatic toxicity associated with gold therapy.

Annals of internal medicine

Favreau M, Tannenbaum H, Lough J.
PMID: 412451
Ann Intern Med. 1977 Dec;87(6):717-9. doi: 10.7326/0003-4819-87-6-717.

Three patients with rheumatoid arthritis developed jaundice after initiation of chrysotherapy. Gold sodium thiomalate had been administered in dosages of 37.5, 60, and 110 mg in these patients before the onset of jaundice. Liver function studies indicated a cholestatic...

Cite
Favreau M, Tannenbaum H, Lough J. Hepatic toxicity associated with gold therapy. Ann Intern Med. 1977;87(6):717-9doi: 10.7326/0003-4819-87-6-717.
Favreau, M., Tannenbaum, H., & Lough, J. (1977). Hepatic toxicity associated with gold therapy. Annals of internal medicine, 87(6), 717-9. https://doi.org/10.7326/0003-4819-87-6-717
Favreau, M, et al. "Hepatic toxicity associated with gold therapy." Annals of internal medicine vol. 87,6 (1977): 717-9. doi: https://doi.org/10.7326/0003-4819-87-6-717
Favreau M, Tannenbaum H, Lough J. Hepatic toxicity associated with gold therapy. Ann Intern Med. 1977 Dec;87(6):717-9. doi: 10.7326/0003-4819-87-6-717. PMID: 412451.
Copy Download .nbib Format: NLM
Quinidine-induced uveitis.

Israel journal of medical sciences

Caraco Y, Arnon R, Raveh D.
PMID: 1399509
Isr J Med Sci. 1992 Oct;28(10):741-3.

No abstract available.

Cite
Caraco Y, Arnon R, Raveh D. Quinidine-induced uveitis. Isr J Med Sci. 1992;28(10):741-3
Caraco, Y., Arnon, R., & Raveh, D. (1992). Quinidine-induced uveitis. Israel journal of medical sciences, 28(10), 741-3.
Caraco, Y, et al. "Quinidine-induced uveitis." Israel journal of medical sciences vol. 28,10 (1992): 741-3.
Caraco Y, Arnon R, Raveh D. Quinidine-induced uveitis. Isr J Med Sci. 1992 Oct;28(10):741-3. PMID: 1399509.
Copy Download .nbib Format: NLM
[Cholestatic hepatosis caused by Talinolol (Cordanum)?].

Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete

Wiese M, Metzner C, Brunner HP, Klemm HP.
PMID: 34271
Z Gesamte Inn Med. 1979 Jan 15;34(2):86-8.

It is reported on a 38-year-old female patient who was treated for 18 days with 150 mg cordanum (talinolol) each and then fell ill with a dyspeptic clinical picture and signs of cholestase. The result of a liver biopsy...

Cite
Wiese M, Metzner C, Brunner HP, et al. Cholestatische Hepatose durch Talinolol (Cordanum)? [Cholestatic hepatosis caused by Talinolol (Cordanum)?]. Z Gesamte Inn Med. 1979;34(2):86-8
Wiese, M., Metzner, C., Brunner, H. P., & Klemm, H. P. (1979). Cholestatische Hepatose durch Talinolol (Cordanum)? [Cholestatic hepatosis caused by Talinolol (Cordanum)?]. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 34(2), 86-8.
Wiese, M, et al. "Cholestatische Hepatose durch Talinolol (Cordanum)?" [Cholestatic hepatosis caused by Talinolol (Cordanum)?]. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete vol. 34,2 (1979): 86-8.
Wiese M, Metzner C, Brunner HP, Klemm HP. Cholestatische Hepatose durch Talinolol (Cordanum)? [Cholestatic hepatosis caused by Talinolol (Cordanum)?]. Z Gesamte Inn Med. 1979 Jan 15;34(2):86-8. German. PMID: 34271.
Copy Download .nbib Format: NLM
[Drug-induced liver diseases].

Polskie Archiwum Medycyny Wewnetrznej

Brzozowski R.
PMID: 471809
Pol Arch Med Wewn. 1979 Apr;61(4):331-8.

No abstract available.

Cite
Brzozowski R. Toksyczne uszkodzenie watroby. [Drug-induced liver diseases]. Pol Arch Med Wewn. 1979;61(4):331-8
Brzozowski, R. (1979). Toksyczne uszkodzenie watroby. [Drug-induced liver diseases]. Polskie Archiwum Medycyny Wewnetrznej, 61(4), 331-8.
Brzozowski, R. "Toksyczne uszkodzenie watroby." [Drug-induced liver diseases]. Polskie Archiwum Medycyny Wewnetrznej vol. 61,4 (1979): 331-8.
Brzozowski R. Toksyczne uszkodzenie watroby. [Drug-induced liver diseases]. Pol Arch Med Wewn. 1979 Apr;61(4):331-8. Polish. PMID: 471809.
Copy Download .nbib Format: NLM
Patterns of hepatic injury induced by methyldopa.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde

Seggie J, Saunders SJ, Kirsch RE, Campbell JA, Gitlin N, Clain D, Terblanche J.
PMID: 424937
S Afr Med J. 1979 Jan 20;55(3):75-83.

Twelve patients with liver disease related to methyldopa were seen between 1967 and 1977. Illness occurred within 1--9 weeks of commencement of therapy in 9 patients, the remaining 3 patients having received the drug for 13 months, 15 months...

Cite
Seggie J, Saunders SJ, Kirsch RE, et al. Patterns of hepatic injury induced by methyldopa. S Afr Med J. 1979;55(3):75-83
Seggie, J., Saunders, S. J., Kirsch, R. E., Campbell, J. A., Gitlin, N., Clain, D., & Terblanche, J. (1979). Patterns of hepatic injury induced by methyldopa. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 55(3), 75-83.
Seggie, J, et al. "Patterns of hepatic injury induced by methyldopa." South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde vol. 55,3 (1979): 75-83.
Seggie J, Saunders SJ, Kirsch RE, Campbell JA, Gitlin N, Clain D, Terblanche J. Patterns of hepatic injury induced by methyldopa. S Afr Med J. 1979 Jan 20;55(3):75-83. PMID: 424937.
Copy Download .nbib Format: NLM
[Morphological and clinical liver changes after taking oral contraceptives].

Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete

Mölleken K, Stahl E, Bretzke G.
PMID: 425584
Z Gesamte Inn Med. 1979 Jan 15;34(2):79-81.

In 155 women of the age group 16-45 years after intake of oral contraceptives in 68.4% (106 cases) histologically provable liver changes were found. Sinusoidal ectasias of different size and drug-conditioned hepatitides most frequently occurred. An isolated intrahepatic cholestase...

Cite
Mölleken K, Stahl E, Bretzke G. Morphologische und klinische Leberbefunde nach Einnahme oraler Kontrazeptiva. [Morphological and clinical liver changes after taking oral contraceptives]. Z Gesamte Inn Med. 1979;34(2):79-81
Mölleken, K., Stahl, E., & Bretzke, G. (1979). Morphologische und klinische Leberbefunde nach Einnahme oraler Kontrazeptiva. [Morphological and clinical liver changes after taking oral contraceptives]. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 34(2), 79-81.
Mölleken, K, et al. "Morphologische und klinische Leberbefunde nach Einnahme oraler Kontrazeptiva." [Morphological and clinical liver changes after taking oral contraceptives]. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete vol. 34,2 (1979): 79-81.
Mölleken K, Stahl E, Bretzke G. Morphologische und klinische Leberbefunde nach Einnahme oraler Kontrazeptiva. [Morphological and clinical liver changes after taking oral contraceptives]. Z Gesamte Inn Med. 1979 Jan 15;34(2):79-81. German. PMID: 425584.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1646 entries